What is cancer proteomics? Cells in your body rely on molecules called proteins to carry out bodily tasks. Cancer cells also rely on proteins to do things such as grow and spread. Cancer proteomics analyzes blood, tumor and tissue samples to identify the proteins in cancer cells that differ from those in normal cells. If a protein is made in larger amounts in cancer cells than in normal cells, it suggests that the protein may play a role in causing cancer to develop or spread. How does the Proteomics platform contribute to our mission of ending cancer? When we find proteins that indicate there's cancer or that play an important role in cancer's progression, we want to further study the protein to see if it's a good target for diagnostic tests or treatment options like targeted therapies or immunotherapies, which can help shrink the cancer. What do you and the rest of your team leading the Proteomics platform do? There are millions of proteins made throughout your body, so finding unique cancer-related proteins means sorting through massive amounts of data. In fact, one drop of blood can provide us with enough data to fill a laptop computer. Our job is to identify cancer-related proteins and help investigators narrow down the massive list of potential targets into those that are most likely to be developed into effective diagnostic tests or cancer drugs. We have a dozen experts that run the proteomics equipment and process, store and analyze the data that comes out it.
Publications/Creative Works
Click here to search for this faculty member's publications on PubMed.
Important Disclaimer: The responsibility for the accuracy of the information contained on these pages lies with the authors and user providing such information.